BMY Stock Today, March 8: First Trust Boosts Stake as Peers Trim
Bristol Myers Squibb stock is in focus for Canadian investors after new 13F data showed a split among big funds. First Trust boosted exposure while others trimmed, setting the stage for flow-driven moves. At USD 60.29 and a 4.13% dividend yield, the setup mixes income with pipeline risk ahead of Q1 results on April 30. We track symbol BMY, where valuation, dividends, and technicals point to balanced risk and reward today. Canadians buying US shares should consider FX costs and how RRSPs treat US dividends versus TFSAs. Institutional positioning and steady cash flows may drive near-term direction.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →